← Back to headlines
Annovis Bio Regains NYSE Listing Compliance
Annovis Bio, a clinical-stage pharmaceutical company, has successfully regained compliance with the New York Stock Exchange's listing requirements.
26 May, 12:22 — 26 May, 12:22
Sources
Showing 1 of 1 sources
